OSTEOSARCOMA IN CHILDREN
Clinical trials for OSTEOSARCOMA IN CHILDREN explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA IN CHILDREN trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA IN CHILDREN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo aims to stop bone Cancer's return
Disease control OngoingThis study tests two drugs—nivolumab alone or with azacitidine—in people whose osteosarcoma (a type of bone cancer) has come back and can be surgically removed. The goal is to see if the treatment is safe and helps keep the cancer from returning after surgery. About 21 adults and…
Matched conditions: OSTEOSARCOMA IN CHILDREN
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
New combo therapy shows promise for tough bone cancer
Disease control OngoingThis study tests a combination of two drugs (regorafenib and nivolumab) in people with osteosarcoma, a type of bone cancer, that has returned or not responded to prior treatment. The goal is to see if this combination can stop the cancer from growing for at least 4 months longer …
Matched conditions: OSTEOSARCOMA IN CHILDREN
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 26, 2026 09:00 UTC